We have just released our latest Frailomic consortium

Welcome to the second issue of the Refractory Asthma Stratification

Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,

The sudden imposition of remote working in response to the 2020 COVID-19

We are looking over the precipice that is a revolution

The scientific literature comprises scholarly publications that report original

Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter

The EUropean Federation for Exploratory MEdicines Development (EUFEMED

In the UK we have a saying that you wait hours for a bus and then two come along at once.

Finding the best vehicle in which to publish your research findings is a perennial challenge.

The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy.

Read the latest newsletter here [1]. In this edition

The comparison of the DPP4 (dipeptidyl peptidase 4) SARS-CoV-2

This essential reading provides readers with a round-up of news on the latest events

Since 2013 we have been sharing our understanding on key issues with friends and clients via our Insider’s Insights.

Niche Science & Technology are playing a key role in the Frailomic project

Our publication on effectiveness of a multimodal intervention

We are looking over the precipice that is a revolution in lifespan modification.

Early in 2020, COVID-19 was spreading rapidly across the globe.

The EUropean Federation for Exploratory MEdicines Development (EUFEMED

Occasionally, a manuscript will be accepted on first submission without revisions.

There have been hundreds of thousands of deaths from COVID-19

The coming year is expected to be a very productive year for the consortium

Work never stops and after the findings of our ground breaking survey in the EMWA

RASP-UK underwent its third progress review by the MRC on 19 May.

Many of the increasing number of elderly in our population

As a jobbing scientist you rarely spend your whole career working on the same project.

Metathesiophobia: from Preclinical to Clinical Development

One notable characteristic of Brexit has been a race for the bottom by journalists

Welcome to the latest edition of the Frailomic Initiative Newsletter.

Read the latest newsletter from both our MID-Frail

Download the third issue of the Refractory Asthma Stratification

Ask anyone and they will tell you that they don’t think they are as old as they are.

I'm sure that everyone works hard and tries to do their best.

According to many observers we are standing on the precipice

Asthma is a chronic inflammatory disorder of the airways

Because new biologic treatments for asthma can be expensive and cause side effects,

In 1786, estimates placed our average life expectancy at just 24 years.

Metathesiophobia: from Preclinical to Clinical Development

It was encouraging to see so many partners at the 2017 General Assembly meeting last December

Many scientists believe that we have reached the end of the life-expectancy revolution

All of our core studies have now completed their clinical phase

Never judge a book by its cover –we know

There are many regulatory documents but perhaps none are more critical

You can now download our latest newsletter, detailing how 2014

Unfortunately, health does not generally improve with age.

When a country’s economy becomes so dominated by a single export industry

We all get them, some of us more than 10 a day, emails from journals

Our publication on the potential benefits of bariatric surgery

Epidemiological data suggest that at two in five of us will experience

Welcome to the latest issue of the Refractory Asthma Stratification Programme (RASP-UK)

Deep Breath is the official newsletter of the UKs Refactory Asthma

Phenotype-specific omic expression patterns in people with frailty could provid

With age comes wisdom, however the physical side of ageing

The latest issue of Journal Frontiers in Pharmacology has just published

The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)

Welcome to the Frailomic Newsletter Update for 2016.

Research into the remarkable regenerative powers of the flatworm Macrostomum lignano a

In this case the plan is a paradigm shift in the way we will manage

ive years ago I was lucky enough to be involved in a project that resulted in publications